Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

OPDC's Associate Professor Laura Parkkinen, and her team has conducted a study published in Brain, funded by the charity Parkinson’s UK and Weston Brain Institute.

The study investigated whether a new protein test could be used as an early diagnostic test in high-risk patients with REM sleep behaviour disorder and measure the progression of Parkinson’s and related disorders i.e.  Multiple System Atrophy.  An early definite diagnostic test could speed up research into new drugs that slow the condition, which could prevent people from ever developing symptoms associated with Parkinson's.

Link to full story

Link to Brain publication